FLC
CORZ icon

Fifth Lane Capital’s Core Scientific CORZ Stock Holding History

Fifth Lane Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99,752
Closed -$1.49M – 18
2026
Q1 		$1.49M Buy
99,752
+56,752
+132% +$968K 1.81% 15
2025
Q4 		$626K Buy
+43,000
New +$750K 0.47% 37

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Fifth Lane Capital's CORZ Position: Q2 2026 in Review

Fifth Lane Capital sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 99,752 shares — an estimated $1.49M sold.

Fifth Lane Capital first reported a position in CORZ in Q4 2025 and held it in 2 quarters. The position peaked at $1.49M in Q1 2026. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Fifth Lane Capital reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
  • Fifth Lane Capital sold 99,752 Core Scientific shares in Q2 2026, an estimated $1.49M.
  • Fifth Lane Capital first reported a position in Core Scientific in Q4 2025 and held it in 2 quarters.
  • Fifth Lane Capital's Core Scientific position peaked at $1.49M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Fifth Lane Capital's 13F filing for Q2 2026, filed 6 Aug 2026.